生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Enalapril Maleate, the active metabolite of enalapril, is an angiotensin-converting enzyme (ACE) inhibitor. Absorption of enalapril maleate (10 mg, p.o.) was rapid, with peak serum concentrations of enalapril observed 0.5-1.5 h after administration[3]. Moreover, treatment with the ACE inhibitor enalapril maleate improved UVB-induced(ultraviolet B) wrinkles and skin damage in hairless mouse skin[4]. Enalapril maleate and folic acid tablets have a protective effect against CIN (contrast-induced nephropathy) in diabetic rats[5]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00603590 | Cardiovascular Disease ... 展开 >> Hypertension Hyperlipidemia Heart Disease 收起 << | Phase 2 | Completed | - | Iran, Islamic Republic of ... 展开 >> Kalaleh Heart Study Center Kalaleh, Golestan, Iran, Islamic Republic of 收起 << |
NCT00603590 | - | Completed | - | - | |
NCT02639637 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.03mL 0.41mL 0.20mL |
10.15mL 2.03mL 1.02mL |
20.30mL 4.06mL 2.03mL |
参考文献 |
---|